Practical Reviews
search for
or search by
Results 1 - 20 of 22
90Y Radioembolization for Locally Advanced Hepatocellular Carcinoma With Portal Vein Thrombosis: Long-Term Outcomes in a 185-Patient Cohort.
Posted Date: 9/10/2018 3:02:00 PM
Issue: Radiology - September 2018 - Vol. 46 - No. 11
Author(s): C. Richard Goldfarb, MD

Subscriber Access Only
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial.
Posted Date: 9/10/2018 3:02:00 PM
Issue: Radiology - September 2018 - Vol. 46 - No. 11
Author(s): David L. Bushnell, MD
177 Lu-Dotatate improves quality of life in patients with metastatic neuroendocrine tumors.
Subscriber Access Only
Antitumor Effects of Radionuclide Treatment Using α-Emitting Meta-211At-Astato-Benzylguanidine in a PC12 Pheochromocytoma Model.
Posted Date: 8/30/2018 8:01:00 PM
Issue: Radiology - August 30, 2018 - Vol. 46 - No. 10
Author(s): David L. Bushnell, MD
Meta- 211 At-astato-benzylguanidine has been found to exhibit a strong tumor volume-reducing effect in a mouse model of pheochromocytoma without severe adverse effects; hence it might be effective in the treatment of malignant pheochromocytoma.
Subscriber Access Only
Selenium Supplementation May Help Protect Salivary Glands After Iodine-131 Therapy for Differentiated Thyroid Cancer.
Posted Date: 6/18/2018 2:40:00 PM
Issue: Radiology - June 30, 2018 - Vol. 46 - No. 8
Author(s): C. Richard Goldfarb, MD
Selenium (300 µg of selenium as inorganic sodium selenite from 3 days before to 6 days after 131 I treatment) may protect salivary glands in patients undergoing high-dose 131 I therapy for differentiated thyroid cancer.
Subscriber Access Only
177Lu-PSMA Radioligand Therapy for Prostate Cancer.
Posted Date: 5/29/2018 9:48:00 PM
Issue: Radiology - May 30, 2018 - Vol. 46 - No. 7
Author(s): David L. Bushnell, MD
177 Lu-PSMA therapy is a promising treatment option for advanced prostate cancer.
Subscriber Access Only
213Bi-PSMA-617 Targeted Alpha-Radionuclide Therapy in Metastatic Castration-Resistant Prostate Cancer.
Posted Date: 4/26/2018 5:20:00 PM
Issue: Radiology - April 30, 2018 - Vol. 46 - No. 6
Author(s): David L. Bushnell, MD
213 Bi can be labeled to a prostate-specific membrane antigen targeting ligand for treatment of advanced prostate cancer.
Subscriber Access Only
Cataract Risk in a Cohort of U.S. Radiologic Technologists Performing Nuclear Medicine Procedures.
Posted Date: 2/26/2018 7:38:00 PM
Issue: Radiology - February 28, 2018 - Vol. 46 - No. 3
Author(s): Mark T. Madsen, PhD, FAAPM, FACR

Subscriber Access Only
Predictability of 99mTc-Galactosyl Human Serum Albumin Scintigraphy for Posthepatectomy Liver Failure.
Posted Date: 2/26/2018 7:38:00 PM
Issue: Radiology - February 28, 2018 - Vol. 46 - No. 3
Author(s): C. Richard Goldfarb, MD
99m Tc-labeled galactosyl-human serum albumin SPECT with reference to CT images provides information in determining a safe resection line for hepatectomy.
Subscriber Access Only
PSMA Targeted Radioligandtherapy in Metastatic Castration Resistant Prostate Cancer After Chemotherapy, Abiraterone and/or Enzalutamide. A Retrospective Analysis of Overall Survival.
Posted Date: 1/29/2018 9:07:00 PM
Issue: Radiology - January 30, 2018 - Vol. 46 - No. 2
Author(s): David L. Bushnell, MD
Prostate-specific membrane antigen targeted radioligand therapy is effective even in heavily pretreated advanced metastatic castration-resistant prostate cancer patients.
Subscriber Access Only
Applications of Ventilation-Perfusion Scintigraphy in Surgical Management of Chronic Obstructive Lung Disease and Cancer.
Posted Date: 10/27/2017 2:12:00 PM
Issue: Radiology - October 30, 2017 - Vol. 45 - No. 10
Author(s): Murthy R. Chamarthy, MD

Subscriber Access Only
Neuroblastoma and MIBG imaging.
Posted Date: 10/27/2017 2:12:00 PM
Issue: Radiology - October 30, 2017 - Vol. 45 - No. 10
Author(s): David L. Bushnell, MD

Subscriber Access Only
Peri- and Postsurgical Evaluations of Renal Transplant.
Posted Date: 10/27/2017 2:12:00 PM
Issue: Radiology - October 30, 2017 - Vol. 45 - No. 10
Author(s): Murthy R. Chamarthy, MD

Subscriber Access Only
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Posted Date: 9/28/2017 2:14:00 PM
Issue: Radiology - September 30, 2017 - Vol. 45 - No. 9
Author(s): David L. Bushnell, MD

Subscriber Access Only
Validation of 2-18F-Fluorodeoxysorbitol (18F-FDS) as a Potential Radiopharmaceutical for Imaging Bacterial Infection in the Lung.
Posted Date: 9/28/2017 2:14:00 PM
Issue: Radiology - September 30, 2017 - Vol. 45 - No. 9
Author(s): Murthy R. Chamarthy, MD

Subscriber Access Only
Chinese Data of Efficacy of Low- and High-Dose Iodine-131 for the Ablation of Thyroid Remnant.
Posted Date: 8/29/2017 8:50:00 PM
Issue: Radiology - August 30, 2017 - Vol. 45 - No. 8
Author(s): C. Richard Goldfarb, MD

Subscriber Access Only
Giant-Cell Arteritis: Concordance Study Between Aortic CT Angiography and FDG-PET/CT in Detection of Large-Vessel Involvement.
Posted Date: 8/29/2017 8:50:00 PM
Issue: Radiology - August 30, 2017 - Vol. 45 - No. 8
Author(s): Murthy R. Chamarthy, MD
Although fluorodeoxyglucose-PET/CT demonstrates higher sensitivity in per-segment detection of giant cell arteritis, CT angiography provides comparable results in per-patient analysis.
Subscriber Access Only
Integrated 18F–FDG PET/MRI Compared to MRI Alone for Identification of Local Recurrences of Soft Tissue Sarcomas: A Comparison Trial.
Posted Date: 8/29/2017 8:50:00 PM
Issue: Radiology - August 30, 2017 - Vol. 45 - No. 8
Author(s): Murthy R. Chamarthy, MD
PET/MRI is an excellent modality for detection of local recurrence in soft tissue sarcoma in comparison to MRI alone.
Subscriber Access Only
Multiple Time-Point 68Ga-PSMA I&T PET/CT for Characterization of Primary Prostate Cancer: Value of Early Dynamic and Delayed Imaging.
Posted Date: 7/26/2017 10:19:00 PM
Issue: Radiology - July 30, 2017 - Vol. 45 - No. 7
Author(s): Murthy R. Chamarthy, MD

Subscriber Access Only
Tc-99m MAA Mapping Prior to Y-90 Liver Radioembolization; Factors That May Affect Pulmonary Shunt Fraction.
Posted Date: 7/26/2017 10:19:00 PM
Issue: Radiology - July 30, 2017 - Vol. 45 - No. 7
Author(s): Murthy R. Chamarthy, MD

Subscriber Access Only
Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?
Posted Date: 7/26/2017 10:19:00 PM
Issue: Radiology - July 30, 2017 - Vol. 45 - No. 7
Author(s): C. Richard Goldfarb, MD

Subscriber Access Only